Is a complete AIM/AGY research report available?

No complete published report is available for aim/AGY (AIM/AGY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/AGY (AIM/AGY)

London Stock Exchange AIM: AIM/AGY · GBX

GBX 5.00

+0.25 (+5.3%)· Recorded snapshot

Market cap	300.8M
Revenue (ttm)	57.3M
Net income (ttm)	-48.2M
EPS (ttm)	-GBX 0.01
Shares out	6.3B
Volume	6,784
Beta	0.83

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 57.3M
Net income (ttm): -48.2M
EPS (ttm): -GBX 0.01
Market cap: 300.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-12 02:00 UTC

All AIM/AGY indicators

Market & fundamental data

Available fields

194

Groups with data

Currency

GBP

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	584
Employees Change	-18%
Employees Change Percent	-2.99
Enterprise value	GBX 317.5M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	18.72
Industry PE Fwd	15.17
Isin	GB00B02LCQ05
Last refreshed	2026-09-12
Market cap	GBX 300.8M
Price	GBX 5
Price currency	GBX
Rev Per Employee	98,106.16x
Sector	Healthcare
Sector PE	20.62
Sector PE Fwd	13.37
Sic	2836
Symbol	aim/AGY
Website	https://www.allergytherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.02%
EV/Sales	5.54x
FCF yield	-12.36%
P/B ratio	70.79x
P/S ratio	5.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-59.58%
EBITDA Margin	-55.16%
Gross margin	52.22%
Gross Profit	GBX 29.9M
Gross Profit Growth	-0.53%
Gross Profit Growth Q	2.96%
Gross Profit Growth3 Y	-8.75%
Gross Profit Growth5 Y	-13.33%
Net Income	GBX -48.2M
Net Income Growth Years	2%
Pretax Margin	-82.33%
Profit Margin	-84.08%
Profit Per Employee	GBX -82,491
ROA	-29.64
Roa5y	-19.42
ROCE	-87.58
ROIC	-163.2
Roic5y	-80.42

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-5.12%
Cagr15y	0.23%
Cagr1y	-37.52%
Cagr20y	-10.42%
Cagr3y	56.18%
Cagr5y	-20.17%
EPS Growth Years	2
Revenue Growth	2.94x
Revenue Growth Q	6.61x
Revenue Growth Qo Q	72.65x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.61x
Revenue Growth5 Y	-6.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.8
Assets	GBX 71M
Cash	GBX 10.1M
Current Assets	GBX 36.3M
Current Liabilities	GBX 32M
Debt	GBX 26.8M
Debt Equity	GBX 6.3
Debt FCF	GBX -0.72
Equity	GBX 4.2M
Interest Coverage	-4.88
Liabilities	GBX 66.8M
Long Term Assets	GBX 34.8M
Long Term Liabilities	GBX 34.7M
Net Cash	GBX -16.7M
Net Cash By Market Cap	GBX -5.54
Net Debt Equity	GBX 3.92
Tangible Book Value	GBX 49,000
Tangible Book Value Per Share	GBX 0
WACC	9.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.13
Inventory Turnover	2.13
Net Working Capital	GBX -3.9M
Quick ratio	0.7
Working Capital	GBX 4.2M
Working Capital Turnover	GBX 5.74

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-40.88%
1Y total return	-37.5%
200-day SMA	9.2
3Y total return	281.1%
50-day SMA	5.72
50-day SMA vs 200-day SMA	50under200
5Y total return	-67.57%
All Time High	146
All Time High Change	-96.58%
All Time High Date	2007-02-05
All Time Low	0.8
All Time Low Change	525%
All Time Low Date	2023-06-22
ATR	0.57
Beta	0.83
Beta1y	0.22
Beta2y	0.29
Ch YTD	-54.55
High	5
High52	12.1
High52 Date	2026-02-26
High52ch	-58.68%
Low	5
Low52	4.5
Low52 Date	2026-09-10
Low52ch	11.11%
Ma50ch	-12.53%
Price vs 200-day SMA	-45.63%
RSI	35.23
RSI Monthly	36.3
RSI Weekly	25.33
Sharpe ratio	-0.64x
Sharpe Ratio3y	0.96x
Sharpe Ratio5y	0.3x
Sortino ratio	-0.77
Sortino Ratio3y	1.57
Sortino Ratio5y	0.46
Total Return	-4.81%
Tr YTD	-54.55
Tr15y	3.46%
Tr1m	-9.09%
Tr1w	-4.76%
Tr3m	-40.48%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	723,464,497%
Net Borrowing	26,706,000
Shares Insiders	0.14%
Shares Institutions	7.27%
Shares Out	6,332,529,550
Shares Qo Q	9.62%
Shares Yo Y	4.81%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -39.1M
Adjusted OCF	-34,481,000
Average Volume	618,911.8x
Bv Per Share	0
CAPEX	GBX -4.6M
Ch10y	-72.8
Ch15y	-52.38
Ch1m	-9.09
Ch1w	-4.76
Ch1y	-37.5
Ch20y	-94.9
Ch3m	-40.48
Ch3y	75.44
Ch5y	-85.07
Ch6m	-56.52
Change	5.26%
Change From Open	0
Close	4.75
Days Gap	5.26
Depreciation Amortization	2,531,000
Dollar Volume	33,920
Earnings Date	2026-12-11
EBIT	GBX -34.1M
EBITDA	GBX -31.6M
EPS	GBX -0.01
F Score	3
FCF	GBX -37.2M
FCF EV Yield	-11.71x
FCF Per Share	GBX -0.01
Financing CF	25,494,000
Fiscal Year End	June
Founded	1,998
Goodwill	3,340,000
Income Tax	GBX 1M
Investing CF	-4,224,000
Is Primary Listing	1
Last Earnings Date	2025-12-29
Last Report Date	2025-12-31
Ma150	8.5
Ma150ch	-41.16%
Ma20	5.27
Ma20ch	-5.05%
Net CF	-11,592,000
Next Earnings Date	2026-12-11
Open	5
Ppne	26,389,000
Price Date	2026-09-11
Ptbv Ratio	6,138.7
Relative Volume	0.01x
Revenue	57,294,000x
SBC By Revenue	3.42x
Share Based Comp	1,958,000
Tax By Revenue	1.76x
Tr20y	-88.92%
Tr6m	-56.52%
Volume	6,784
Z Score	-2.17

AIM/AGY (AIM/AGY)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/AGY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/AGY indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on AIM/AGY

Frequently asked questions